A Phase II Study of Paclitaxel and Nedaplatin as First-line Chemotherapy in Patients with Advanced Esophageal Cancer
Year: 2009
Type: article
Study design: Clinical Trial
DOI: 10.1093/jjco/hyp058
Institutions: Shanghai Jiao Tong University, Ruijin Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: paclitaxel, nedaplatin, combination chemotherapy, first-line chemotherapy, advanced esophageal cancer, treatment toxicity, anemia, neutropenia, thrombocytopenia, nausea and vomiting, overall survival, time to progression, treatment response rate, treatment tolerability, treatment complications
Open Access status: closed
OpenAlex ID: W2147102121
